M&A Deal Summary |
|
|---|---|
| Date | 2002-08-01 |
| Target | Oculex Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) |
Aisling Capital
Bay City Capital |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 1.8B USD |
| Size | Large |
| Type | Sector Focused |
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 56 |
| Sector (Life Science) | 2 of 42 |
| Type (Buyout (LBO, MBO, MBI)) | 1 of 6 |
| State (California) | 1 of 15 |
| Country (United States) | 2 of 52 |
| Year (2002) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2001-09-27 |
Novazyme Pharmaceuticals
Oklahoma City, Oklahoma, United States Novazyme is a development stage biotechnology company focused on drugs to treat lysosomal storage diseases |
Sell | $137M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2003-11-20 |
Oculex Pharmaceuticals
Sunnyvale, California, United States Oculex Pharmaceuticals, Inc. is an Ophthalmic drug delivery company. |
Sell | $230M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1997 |
| PE ASSETS | 1.3B USD |
| Size | Large |
| Type | Sector Focused |
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 32 of 75 |
| Sector (Life Science) | 21 of 54 |
| Type (Buyout (LBO, MBO, MBI)) | 10 of 18 |
| State (California) | 14 of 41 |
| Country (United States) | 30 of 72 |
| Year (2002) | 6 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-07-15 |
Itamar Medical
Caesarea, Israel Itamar Medical is a medical device company which develops, markets and sells diagnostic medical devices based on the PAT™ (Peripheral Arterial Tone) signal. The PAT signal is a non-invasive "window" to the cardiovascular system and the autonomic nervous system. Itamar Medical was founded in 1997 and is based in Caesarea, Israel. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-11-01 |
Pathway Diagnostics
Malibu, California, United States Pathway Diagnostics Corp. is a full-service biomarker assay development and commercialization company that uniquely combines expertise in clinical biomarker diagnostics with access to intellectual property, a broad range of technology platforms, and full-service central laboratory for clinical trials that is licensed under CLIA/CAP and compliant with GLP/GCP regulations. |
Buy | - |
